HYPD
Biotechnology · Healthcare
CFO
2025-09-29–present
Equibles does not estimate personal net worth.
David Knox is recorded as CFO at Hyperion Defi, Inc. (HYPD). The newest filing on record that lists David Knox as CFO at Hyperion Defi, Inc. (HYPD) is dated May 5, 2026. Hyperion Defi, Inc. reported in an 8-K filed September 29, 2025 that David Knox was appointed Treasurer, effective September 29, 2025. Hyperion Defi, Inc. reported in an 8-K filed September 29, 2025 that David Knox was appointed Chief Financial Officer, effective September 29, 2025. David Knox has spoken on 3 earnings calls across 1 company, most recently for Hyperion Defi, Inc. on August 12, 2026. Hyperion Defi, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hyperion Defi, Inc. includes Hyunsu Jung (CEO, CIO and Board Member), Michael Rowe (CEO, COO and Board Member), Andrew D. Jones (CFO) and 7 others.
“Effective September 29, 2025, the Board of Directors (the "Board") of Hyperion DeFi, Inc. (the "Company") appointed David Knox to the positions of Chief Financial Officer, Treasurer and Secretary of the Company.”
“Effective September 29, 2025, the Board of Directors (the "Board") of Hyperion DeFi, Inc. (the "Company") appointed David Knox to the positions of Chief Financial Officer, Treasurer and Secretary of the Company.”
“In June of 2025, we set out to establish a new kind of company, one which is blockchain and DeFi native and shares in multiple frontiers of value creation at the same time.”
“As Hyunsu already noted, today, we are raising our 2026 full year guidance by approximately 20% or plus $1 million to $5 million to $7 million of adjusted gross profit, driven by the momentum of our businesses, the immense opportunities we see and our success in raising $10 million in a public offering last week.”
“I'm pleased to join Hyperion DeFi as Chief Financial Officer and participate in my first earnings call with the company. My appointment became effective on September 29, so I've been able to observe our Q3 results from both an external and internal perspective.”
SEC 8-K
2025-09-29–present
Start not stated–present
Last confirmed May 5, 2026
HYPD
Biotechnology · Healthcare
CFO
2025-09-29–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Hyperion Defi, Inc. (HYPD) | Chief Financial Officer | — | — |